The role and mechanism of MD-LELCs induced by tumor microenvironment remodeling in tumor lymphangiogenesis

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100044922

Enrollment

Unknown

Registered

2021-03-31

Start date

2021-06-01

Completion date

Unknown

Last updated

2021-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tumor lymphogenesis

Interventions

Adjacent normal tissue group:None

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Patients diagnosed with breast cancer for the first time; 2.No clinical treatment.

Exclusion criteria

Exclusion criteria: None.

Design outcomes

Primary

Measure	Time frame
The content of hyaluronan;The number of Macrophage derived lymphatic endothelial like cells;	—

Countries

China

Contacts

Public ContactDu Yan

Shanghai Sixth People's Hospital

siyi19842993@126.com+86 18930174323

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026